Mast cell activation syndrome, or MCAS, is an immunological condition where the mast cells in the body release excessive amounts of chemical mediators such as histamine, leading to symptoms such as hives, flushing, rashes, swelling, low blood pressure, dizziness, brain fog, breathing difficulties, and even anaphylaxis
this represents the most advanced program targeting cognitive enhancement through longevity pathways Combination approaches: GLP-1 agonists combined with anti-amyloid therapies or mitochondrial-targeted agents may address multiple pathological pathways
however, this is entirely normal and will subside on its own
However, several studies demonstrated that AD patients have reduced, not elevated, brain and cerebrospinal fluid copper level [24, 25]
We also recommend some high-quality supplements that deliver these antioxidants